Vergent Bioscience, Inc
✓ AI-Ready Profile76
AI Score
🤖 AI-Optimized Summary
Vergent Bioscience’s lead compound, VGT-309, is a tumor-targeted fluorescent imaging agent intentionally designed to enable surgeons to see previously undetected or difficult-to-find tumors during surgery in real-time, ensuring all solid tumor tissue is removed.
📋 Business Details
Is this your business?
Claim this profile to improve your AI Visibility Score and get verified.
Claim My AI Profile →